Thursday, October 20, 2022 9:58:50 AM
The end is near (Speculation)
https://www.reddit.com/r/RVVTF/comments/y87v71/the_end_is_near/
I did not want to post this from this morning.This of course actually has me very worried about the endpoint change but of course I will be holding. I also could not find any Real Proof of Experience with Phase 3 trials or Fda, either when I searched a while ago for Arshi Kizilbash. Also of course some of the other stuff bob posted in the reddit post is even more to worry about etc..
https://www.linkedin.com/in/drarshikizilbash/?originalSubdomain=br
Reddit post here. But now im reading it just got deleted as I run out of time to to edit this post ...
https://www.reddit.com/r/RVVTF/comments/y8wign/regrettably_i_now_have_concerns_about_our/
ps. just going to try to get through Today...at work that is
pps, maybe they need to really take into consideration what Bmt is saying?
https://www.reddit.com/r/RVVTF/comments/y87v71/the_end_is_near/
I did not want to post this from this morning.This of course actually has me very worried about the endpoint change but of course I will be holding. I also could not find any Real Proof of Experience with Phase 3 trials or Fda, either when I searched a while ago for Arshi Kizilbash. Also of course some of the other stuff bob posted in the reddit post is even more to worry about etc..
https://www.linkedin.com/in/drarshikizilbash/?originalSubdomain=br
Reddit post here. But now im reading it just got deleted as I run out of time to to edit this post ...
https://www.reddit.com/r/RVVTF/comments/y8wign/regrettably_i_now_have_concerns_about_our/
ps. just going to try to get through Today...at work that is
pps, maybe they need to really take into consideration what Bmt is saying?
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
